HH

Hamid R. Hoveyda

OS Ogeda Sa: 5 patents #1 of 6Top 20%
ET Epics Therapeutics: 2 patents #1 of 4Top 25%
Overall (2020): #19,391 of 565,922Top 4%
7
Patents 2020

Issued Patents 2020

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
10836768 N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists Guillaume Dutheuil, Graeme L. Fraser 2020-11-17
10787458 Chiral synthesis of N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-A]pyrazines Guillaume Dutheuil 2020-09-29
10781171 Substituted pyrrolidines as G-protein coupled receptor 43 agonists Didier Schils, Ludivine Zoute, Julien Parcq 2020-09-22
10683295 Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-A]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof Guillaume Dutheuil, Graeme L. Fraser, Marie-Odile Roy, Mohamed El Bousmaqui, Frederic Batt 2020-06-16
10624890 NK-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat Graeme L. Fraser 2020-04-21
10577318 Substituted pyrrolidines as G-protein coupled receptor 43 agonists Didier Schils, Ludivine Zoute, Julien Parcq 2020-03-03
10544150 NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders Marie-Odile Roy, Graeme L. Fraser, Guillaume Dutheuil 2020-01-28